+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Body Contouring Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • PDF Icon

    Report

  • 120 Pages
  • February 2024
  • Region: Global
  • Mordor Intelligence
  • ID: 5025842
The body contouring devices market is poised to register a CAGR of 17% over the forecast period.

Key Highlights

  • The COVID-19 pandemic had a significant impact on the body contouring device market. For instance, an article published by Aesthetic Plastic Surgery in April 2023 observed that the motivation level of the participants who underwent facial, body contouring, and rhinoplasty surgery for 'bothered by their appearance in the mirror' was statistically significantly lower during the pandemic period compared to the pre-pandemic period. However, as the market is returning to its pre-pandemic state due to the decline in COVID-19 cases and increased concern about body aesthetics, the market will show significant growth over the forecast period.
  • The growing adoption of minimally invasive body contouring procedures and advancements in device technologies are the major factors that are boosting the growth of the body contouring devices market. For instance, according to the World Health Organization Report in March 2022, over 1 billion individuals, including 650 million adults, 340 million teenagers, and 39 million children, are obese worldwide. Additionally, 167 million adults and children will have worse health by 2025 as a result of being overweight or obese. Thus, with the increase in the obese population, the demand for body contouring is expected to increase over the forecast period.
  • Furthermore, the companies are actively involved in new product launch developments and collaborations to expand their footprint. For instance, in April 2023, Apyx Medical Corporation received 510(k) clearance from the U.S. FDA for the use of the Renuvion APR Handpiece "for coagulation of subcutaneous soft tissues following liposuction for aesthetic body contouring." It demonstrated the safety and effectiveness of Renuvion technology and continued commitment to working with the FDA to secure specific clinical indications.
  • Thus, all aforementioned factors are expected to boost market growth over the forecast period. However, there is a high cost of body contouring devices and a lack of awareness in many parts of the world.

Body Contouring Devices Market Trends

Ultrasound Body Contouring Devices Segment is Expected to Hold a Major Share in the Medical Device Market

  • Radiofrequency (RF) devices noninvasively tighten and contour the skin and body with minimal to no downtime. RF devices can be categorized as monopolar, unipolar, bipolar, and multipolar based on the number of electrodes used and how the energy is delivered to the tissues beneath the skin. The segment growth is attributed to the advantage of radiofrequency (RF) devices over other devices and the initiative taken by key players for the development of the market.
  • For instance, according to an article published by the Multidisciplinary Digital Publishing Institute (MDPI) in August 2022, treatments to reduce abdominal adipose tissue with ultrasound, radiofrequency, or both techniques provided the desired cosmetic effect. Radiofrequency treatment was the most efficient modality since it produced a long-term cosmetic effect (lasting for at least 6 months), reflected in reduced body weight, BMI, and waist circumference. Thus, the advantages associated with radiofrequency (RF) devices are expected to drive segmental growth.
  • Furthermore, to meet the rising demand, market players are taking various strategic initiatives. For instance, in April 2022, Aesthetic Management Partners (AMP) signed an exclusive three-year agreement with Agnes Medical to market Agnes RF, a precision radiofrequency macro needling device. The partnership strengthens an ongoing relationship by making Aesthetic Management Partners the sole distributor in the United States after adding California as part of this new agreement.
  • Thus, owing to the factors above, the usage of radiofrequency devices is expected to grow significantly during the forecast period.


North America is Expected to Hold a Significant Share in the Body Contouring Devices Market

  • North America holds the largest share in the body contouring devices market owing to the high population boom, high obesity prevalence, and high inclination towards aesthetic surgeries. For instance, according to an article published by BMC Health Services Research, in March 2022, more than two-thirds of the post-bariatric population in the United States desire to have contouring surgeries. The availability of ambulatory surgical centers facilitated increased patient access to most elective surgeries by lowering costs, including abdominoplasty, which is principally (48.8%) performed in ambulatory surgical centers. This is likely to impact the market growth in the region positively.
  • Furthermore, the product launches by the key market players are expected to boost market growth. For instance, in July 2022, BTL, the authority in non-invasive body sculpting therapies, launched the new Edge Applicators. The device is designed for the better contour of the curvy areas of the body. Moreover, there has been an increased shift toward minimally invasive procedures in the United States as they have less pain and time after the procedures.
  • Hence, owing to the above-mentioned factors, the market is expected to grow exponentially.


Body Contouring Devices Industry Overview

The body contouring devices market is moderately concentrated in nature due to the presence of companies operating globally and regionally. The competitive landscape includes analyzing companies, including Hologic Inc., Candela Corporation, Bausch Health Companies Inc., Allergan Plc, and Leumenis, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support


This product will be delivered within 2 business days.

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Adoption of Minimally Invasive Body Contouring Procedures
4.2.2 Advancements In Device Technologies
4.3 Market Restraints
4.3.1 High Cost of Body Contouring Devices
4.3.2 Lack of Awareness in Many Parts of the World
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Product Type
5.1.1 Minimally Invasive and Non Invasive Devices
5.1.1.1 Radiofrequency Body Contouring Devices
5.1.1.2 Ultrasound Body Contouring Devices
5.1.1.3 Laser Assisted Body Contouring Devices
5.1.2 Invasive Devices
5.2 By Application
5.2.1 Fat Reduction
5.2.2 Skin Tightening
5.2.3 Other Applications
5.3 By End-User
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Other End-Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle Eastst and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Hologic Inc. (Cynosure)
6.1.2 AbbVie (Allergan Plc)
6.1.3 Candela Corporation
6.1.4 Boston scientific (Lumenis)
6.1.5 Bausch Health Companies Inc
6.1.6 Alma Lasers Ltd.
6.1.7 MicroAire Surgical Instruments, LLC
6.1.8 Nouvag AG
6.1.9 BTL Aesthetics
6.1.10 Merz Pharma Gmbh
7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Hologic Inc. (Cynosure)
  • Allergan Plc
  • Candela Corporation
  • Lumenis
  • Bausch Health Companies Inc
  • Alma Lasers Ltd.
  • MicroAire Surgical Instruments, LLC
  • Nouvag AG

Methodology

Loading
LOADING...